Feasibility of [[sup.18]F]FSPG PET for Early Response Assessment to Combined Blockade of EGFR and Glutamine Metabolism in Wild-Type IKRAS/I Colorectal Cancer

Early response assessment is critical for personalizing cancer therapy. Emerging therapeutic regimens with encouraging results in the wild-type (WT) KRAS colorectal cancer (CRC) setting include inhibitors of epidermal growth factor receptor (EGFR) and glutaminolysis. Towards predicting clinical outc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Tomography (Ann Arbor) 2023-02, Vol.9 (2)
Hauptverfasser:	Bae, Seong-Woo, Wang, Jianbo, Georgiou, Dimitra K, Wen, Xiaoxia, Cohen, Allison S, Geng, Ling, Tantawy, Mohammed Noor, Manning, H. Charles
Format:	Artikel
Sprache:	eng
Schlagworte:	Colorectal cancer Glutamine Health aspects Panitumumab Physiological aspects Resveratrol
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!